421 related articles for article (PubMed ID: 15731030)
21. Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen.
Hu JC; Mathias-Santos C; Greene CJ; King-Lyons ND; Rodrigues JF; Hajishengallis G; Ferreira LC; Connell TD
PLoS One; 2014; 9(12):e113978. PubMed ID: 25536061
[TBL] [Abstract][Full Text] [Related]
22. Variation in chemical properties and antigenic determinants among type II heat-labile enterotoxins of Escherichia coli.
Guth BE; Twiddy EM; Trabulsi LR; Holmes RK
Infect Immun; 1986 Nov; 54(2):529-36. PubMed ID: 2429930
[TBL] [Abstract][Full Text] [Related]
23. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.
Norton EB; Lawson LB; Freytag LC; Clements JD
Clin Vaccine Immunol; 2011 Apr; 18(4):546-51. PubMed ID: 21288994
[TBL] [Abstract][Full Text] [Related]
25. LT-IIc, a new member of the type II heat-labile enterotoxin family encoded by an Escherichia coli strain obtained from a nonmammalian host.
Nawar HF; King-Lyons ND; Hu JC; Pasek RC; Connell TD
Infect Immun; 2010 Nov; 78(11):4705-13. PubMed ID: 20713622
[TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of the ganglioside-binding activity of the type II Escherichia coli heat-labile enterotoxin LT-IIb.
Connell TD; Holmes RK
Mol Microbiol; 1995 Apr; 16(1):21-31. PubMed ID: 7651134
[TBL] [Abstract][Full Text] [Related]
27. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge.
Beignon AS; Briand JP; Muller S; Partidos CD
Immunology; 2001 Mar; 102(3):344-51. PubMed ID: 11298834
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S
Vaccine; 2001 Feb; 19(15-16):2071-9. PubMed ID: 11228379
[TBL] [Abstract][Full Text] [Related]
29. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
[TBL] [Abstract][Full Text] [Related]
30. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
Bowman CC; Clements JD
Infect Immun; 2001 Mar; 69(3):1528-35. PubMed ID: 11179323
[TBL] [Abstract][Full Text] [Related]
31. The Type II heat-labile enterotoxins LT-IIa and LT-IIb and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells.
Hajishengallis G; Nawar H; Tapping RI; Russell MW; Connell TD
Infect Immun; 2004 Nov; 72(11):6351-8. PubMed ID: 15501764
[TBL] [Abstract][Full Text] [Related]
32. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.
Dickinson BL; Clements JD
Infect Immun; 1995 May; 63(5):1617-23. PubMed ID: 7729864
[TBL] [Abstract][Full Text] [Related]
33. Enhanced antigen uptake by dendritic cells induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2.
Lee CH; Nawar HF; Mandell L; Liang S; Hajishengallis G; Connell TD
Vaccine; 2010 May; 28(21):3696-705. PubMed ID: 20332049
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.
Greene CJ; Hu JC; Vance DJ; Rong Y; Mandell L; King-Lyons N; Masso-Welch P; Mantis NJ; Connell TD
J Leukoc Biol; 2016 Aug; 100(2):361-9. PubMed ID: 27059843
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunization.
De Magistris MT; Pizza M; Douce G; Ghiara P; Dougan G; Rappuoli R
Dev Biol Stand; 1998; 92():123-6. PubMed ID: 9554265
[TBL] [Abstract][Full Text] [Related]
36. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.
Greene CJ; Marks LR; Hu JC; Reddinger R; Mandell L; Roche-Hakansson H; King-Lyons ND; Connell TD; Hakansson AP
Infect Immun; 2016 Jun; 84(6):1693-1703. PubMed ID: 27001538
[TBL] [Abstract][Full Text] [Related]
37. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants.
Douce G; Giannelli V; Pizza M; Lewis D; Everest P; Rappuoli R; Dougan G
Infect Immun; 1999 Sep; 67(9):4400-6. PubMed ID: 10456880
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the LTK63 adjuvant effect on cellular immune responses to measles virus nucleoprotein.
Erume J; Partidos CD
Afr Health Sci; 2011 Jun; 11(2):151-7. PubMed ID: 21857843
[TBL] [Abstract][Full Text] [Related]
39. Ganglioside-binding specificities of E. coli enterotoxin LT-IIc: Importance of long-chain fatty acyl ceramide.
Berenson CS; Nawar HF; Kruzel RL; Mandell LM; Connell TD
Glycobiology; 2013 Jan; 23(1):23-31. PubMed ID: 22917572
[TBL] [Abstract][Full Text] [Related]
40. Cloning, nucleotide sequence, and hybridization studies of the type IIb heat-labile enterotoxin gene of Escherichia coli.
Pickett CL; Twiddy EM; Coker C; Holmes RK
J Bacteriol; 1989 Sep; 171(9):4945-52. PubMed ID: 2670900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
